BioMarin pays $691mm in cash plus up to $160mm in earn-outs for Prosensa
- Antisense, Oligonucleotides
- Drug Discovery Tools
- Large Molecule
- Full Acquisition
- Payment Includes Cash
- Includes Contract
- Includes Earnout
- Intra-Biotech Deal
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.